Bactericidal/permeability-increasing protein (BPI) is a neutrophil primary granule protein that inhibits effects of LPS in vitro. The current study examined the effects of BPI on hemodynamics, mortality, and circulating endotoxin and cytokines in conscious rats with endotoxic shock. Catheters were implanted into the right femoral artery and vein. 1 d later, human recombinant BPI (10 mg/kg) or vehicle was intravenously injected immediately, 30 min, or 2 h after intravenous injection of LPS (7.5 mg/kg). Mean arterial pressure (MAP) and heart rate were monitored and blood was collected before and after injection. BPI given immediately or 30 min after LPS prevented the LPS-induced reduction in MAP at 4-8 h and markedly reduced mortality. BPI given 2 h after LPS injection had no protective effect. BPI treated immediately after LPS reduced the circulating levels of endotoxin and IL-6 but increased the circulating levels of TNF. We propose that BPI exerts its protective effect through a TNF-independent mechanism, by inhibiting endotoxin-stimulated production of IL-6.
H Jin, R Yang, S Marsters, A Ashkenazi, S Bunting, M N Marra, R W Scott, J B Baker
Title and authors | Publication | Year |
---|---|---|
A Polymorphism of Bactericidal/Permeability-Increasing Protein Affects Its Neutralization Efficiency towards Lipopolysaccharide
K Ederer, J Holzinger, K Maier, L Zeller, M Werner, M Toelge, A Gessner, S Bülow |
International journal of molecular sciences | 2022 |
Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock
A Balakrishnan, P DasSarma, O Bhattacharjee, JM Kim, S DasSarma, D Chakravortty |
Scientific Reports | 2016 |
Pilot experience with opebacan/rBPI21 in myeloablative hematopoietic cell transplantation
E Guinan, DE Avigan, RJ Soiffer, NJ Bunin, LL Brennan, I Bergelson, S Brightman, A Ozonoff, PJ Scannon, O Levy |
F1000Research | 2015 |
Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death
EC Guinan, CM Barbon, LA Kalish, K Parmar, J Kutok, CJ Mancuso, L Stoler-Barak, EE Suter, JD Russell, CD Palmer, LC Gallington, A Voskertchian, JA Vergilio, G Cole, K Zhu, A D’Andrea, R Soiffer, JP Weiss, O Levy |
Science Translational Medicine | 2011 |
Increased bactericidal/permeability increasing protein in patients with cirrhosis
A Guerra-Ruiz, F Casafont, M Cobo, A TerÃn, JÃ de-la-PeÃa, A Estebanez, F Pons-Romero |
Liver International | 2010 |
Murine Bactericidal/Permeability-Increasing Protein Inhibits the Endotoxic Activity of Lipopolysaccharide and Gram-Negative Bacteria
I Wittmann, M Schönefeld, D Aichele, G Groer, A Gessner, M Schnare |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Wilderness Medicine
PH Hackett, RC Roach |
Wilderness Medicine | 2007 |
Bactericidal/permeability increasing protein attenuates the myocardial inflammation/dysfunction that occurs with burn complicated by subsequent infection
JW Horton, DL Maass, DJ White, JP Minei |
Journal of applied physiology | 2007 |
Isolation, Cloning, and Characterization of a Novel Phosphomannan-binding Lectin from Porcine Serum
BY Ma, N Nakamura, V Dlabac, H Naito, S Yamaguchi, M Ishikawa, M Nonaka, M Ishiguro, N Kawasaki, S Oka, T Kawasaki |
The Journal of biological chemistry | 2007 |
Antagonistic antibody prevents toll-like receptor 2 driven lethal shock-like syndromes
Guangxun Meng, Mark Rutz, Matthias Schiemann, Jochen Metzger, Alina Grabiec, Ralf Schwandner, Peter B. Luppa, Frank Ebel, Dirk H. Busch, Stefan Bauer, Hermann Wagner, Carsten J. Kirschning |
Journal of Clinical Investigation | 2004 |
Dual Receptors and Distinct Pathways Mediate Interleukin-1 Receptor-associated Kinase Degradation in Response to Lipopolysaccharide: INVOLVEMENT OF CD14/TLR4, CR3, AND PHOSPHATIDYLINOSITOL 3-KINASE
S Noubir, Z Hmama, NE Reiner |
The Journal of biological chemistry | 2004 |
Anti-inflammatory strategies for the treatment of sepsis
NC Riedemann, PA Ward |
Expert Opinion on Biological Therapy | 2003 |
A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice
MG Vallespi, JC Alvarez-Obregón, I Rodriguez-Alonso, T Montero, H Garay, O Reyes, MJ Araña |
International Immunopharmacology | 2003 |
Recombinant Bactericidal/Permeability-Increasing Protein (rBPI21) for Treatment of Parvovirus Enteritis: A Randomized, Double-Blinded, Placebo-Controlled Trial
CM Otto, CB Jackson, EJ Rogell, RB Prior, WS Ammons |
Journal of Veterinary Internal Medicine | 2001 |
Human Endotoxemia Activates p38 MAP Kinase and p42/44 MAP Kinase, But Not c-Jun N-terminal Kinase
B van den Blink, J Branger, S Weijer, SJ van Deventer, T van der Poll, MP Peppelenbosch |
Molecular Medicine | 2001 |
Role of the Classical Pathway of Complement Activation in Experimentally Induced Polymicrobial Peritonitis
JD Clements, I Celik, C Stover, M Botto, S Thiel, S Tzima, D Künkel, M Walport, W Lorenz, W Schwaeble |
Infection and immunity | 2001 |
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins
JR Rose, MA Mullarkey, WJ Christ, LD Hawkins, M Lynn, Y Kishi, KM Wasan, K Peteherych, DP Rossignol |
Antimicrobial agents and chemotherapy | 2000 |
Myocarditis
AM Feldman, D McNamara |
New England Journal of Medicine | 2000 |
Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model
T Sawa, K Kurahashi, M Ohara, MA Gropper, V Doshi, JW Larrick, JP Wiener-Kronish |
Antimicrobial agents and chemotherapy | 1998 |
A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats
DJ Brackett, MR Lerner, MA Lacquement, R He, HA Pereira |
Infection and immunity | 1997 |
Life-Threatening Coagulation Disorders in Critical Care Medicine
V Hach-Wunderle, PP Nawroth |
1997 | |
Biochemistry and cell biology of bacterial endotoxins
O Holst, AJ Ulmer, H Brade, HD Flad, ET Rietschel |
FEMS Immunology & Medical Microbiology | 1996 |
Lebensbedrohliche Gerinnungsstörungen in der Intensivmedizin
V Hach-Wunderle, PP Nawroth |
1996 |